Poster presentations

Abstract

In this way, programmes of food derivatives can be implemented, which, in contrast to the targeted, monotherapeutic and pharmaceutical approach, act on a series of parallel processes. For example, in treating coronary artery disease, it is possible to assemble a pharmaconutritional support programme which will normalize both blood chemistry and vascular physiology. In summary, the pharmaco-nutritional approach allows the physician to combine agents which reduce excessive inflammatory, oxidative, nitrosative and glycative stress, and reduce or reverse cross-link formation. As these core processes underlie much degenerative disease, this approach holds out the prospects of achieving considerable delays in the onset of age-related morbidities. This presentation will review the causes of type B malnutrition, analyse some of its effects on disease processes and outline the pharmaco-nutritional approaches to the management and prevention of coronary artery disease and osteoporosis.